Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-28

Clinical Trial Update: MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation [NA]

View source ↗

Summary

Completed clinical trial evaluating the safety and efficacy of MyopiaX for reducing myopia progression in children and adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MyopiaX

Snippet

Sponsor: Dopavision GmbH | Conditions: Myopia | NA | Status: COMPLETED